John Rondoni Inspire Medical Systems, Inc. (INSP) insider trading activity

INSP Quotes by TradingView

John Rondoni is Chief Technology Officer of Inspire Medical Systems, Inc.. Currently has a direct ownership of 15,500 shares of INSP, which is worth approximately $2.52 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 2,287 shares (Common Stock) at a price of $185.6 per share, resulting in proceeds of $424,467. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.5K
36.59% 3M change
1.0% 12M change
Total Value Held $2.52 Million

John Rondoni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Open market or private sale
$424,467 $185.6 p/Share
2,287 Reduced 12.86%
15,500 Common Stock
Feb 24 2025
SELL
Payment of exercise price or tax liability
$188,128 $186.45 p/Share
1,009 Reduced 5.37%
17,787 Common Stock
Feb 24 2025
BUY
Grant, award, or other acquisition
-
3,296 Added 14.92%
18,796 Common Stock
Feb 13 2025
BUY
Grant, award, or other acquisition
-
5,076 Added 24.67%
15,500 Common Stock
Feb 11 2025
SELL
Open market or private sale
$99,395 $170.49 p/Share
583 Reduced 5.3%
10,424 Common Stock
Feb 09 2025
SELL
Payment of exercise price or tax liability
$57,377 $182.15 p/Share
315 Reduced 2.78%
11,007 Common Stock
Jan 07 2025
SELL
Open market or private sale
$12,470 $215.0 p/Share
58 Reduced 0.51%
11,322 Common Stock
Nov 01 2024
SELL
Open market or private sale
$1,692,994 $194.53 p/Share
8,703 Reduced 43.4%
11,348 Common Stock
Nov 01 2024
BUY
Exercise of conversion of derivative security
$492,415 $56.58 p/Share
8,703 Added 30.27%
20,051 Common Stock
Sep 09 2024
SELL
Open market or private sale
$6,665 $215.0 p/Share
31 Reduced 0.27%
11,348 Common Stock
Aug 22 2024
SELL
Open market or private sale
$948,000 $189.6 p/Share
5,000 Reduced 30.53%
11,379 Common Stock
Aug 22 2024
BUY
Exercise of conversion of derivative security
$355,000 $71.0 p/Share
5,000 Added 23.39%
16,379 Common Stock
Mar 22 2024
SELL
Open market or private sale
$853,096 $194.46 p/Share
4,387 Reduced 28.02%
11,270 Common Stock
Feb 29 2024
SELL
Open market or private sale
$1,545,544 $179.61 p/Share
8,605 Reduced 35.47%
15,657 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
$16,560 $2.07 p/Share
8,000 Added 24.8%
24,262 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
2,694 Added 14.21%
16,262 Common Stock
Mar 08 2023
BUY
Exercise of conversion of derivative security
$9,081 $2.07 p/Share
4,387 Added 24.56%
13,478 Common Stock
Feb 08 2023
SELL
Open market or private sale
$668,750 $267.5 p/Share
2,500 Reduced 21.57%
9,091 Common Stock
Feb 06 2023
SELL
Open market or private sale
$876,260 $250.36 p/Share
3,500 Reduced 23.19%
11,591 Common Stock
Jan 03 2023
SELL
Open market or private sale
$299,520 $256.0 p/Share
1,170 Reduced 7.2%
15,091 Common Stock
Dec 19 2022
SELL
Open market or private sale
$170,666 $251.72 p/Share
678 Reduced 4.01%
16,230 Common Stock
Sep 23 2022
BUY
Exercise of conversion of derivative security
$5,845 $0.94 p/Share
6,218 Added 26.98%
16,828 Common Stock
JR

John Rondoni

Chief Technology Officer
Golden Valley, MN

Track Institutional and Insider Activities on INSP

Follow Inspire Medical Systems, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSP shares.

Notify only if

Insider Trading

Get notified when an Inspire Medical Systems, Inc. insider buys or sells INSP shares.

Notify only if

News

Receive news related to Inspire Medical Systems, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INSP